FDA Adverse Event Injury Summary report: N

PIPELINE EMBOLIZATION DEVICE

MDR report key: 3033009 · Received April 3, 2013

Report

Report Number
2029214-2013-00312
Event Type
Injury
Date Received
April 3, 2013
Date of Event
March 7, 2013
Report Date
March 7, 2013
Manufacturer
EV3 NEUROVASCULAR
Product Code
OUT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PUSHWIRE AND THE PIPELINE WERE RETURNED FOR EVALUATION SEPARATED. THE BRAIDS ON THE PIPELINE WERE FOUND TO BE DAMAGED ALONG WITH CLOTTED BLOOD WHICH LIKELY PREVENTED THE PIPELINE FROM FULLY OPENING. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

TREATMENT OF A LEFT UNRUPTURED CAV (CAVERNOUS) ANEURYSM MEASURING 19MM X 7MM. IT WAS REPORTED THAT THE PATIENT UNDERWENT PIPELINE EMBOLIZATION TREATMENT INVOLVING TWO PIPELINES. THE FIRST PIPELINE COULD NOT BE RELEASED FROM THE CAPTURE COIL AND IT WAS REMOVED FROM THE PATIENT. THE SECOND PIPELINE RELEASED FROM THE CAPTURE COIL; HOWEVER, THE PROXIMAL END WOULD NOT OPEN. AFTER SEVERAL FAILED ATTEMPTS TO OPEN THE PROXIMAL END, THE PIPELINE WAS REMOVED FROM THE PATIENT WITH A SNARE. NO INJURY WAS REPORTED WITH THE PATIENT AS A RESULT OF THE PROCEDURE. SAME EVENT AS MDR# 2029214-2013-00311.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
136161 PIPELINE EMBOLIZATION DEVICE FLOW DIVERSION OUT EV3 NEUROVASCULAR FA-77500-18 9694816

Patients

Seq Age Sex Outcome Treatment
1 65 YR Required Intervention